A study to evaluate the efficacy, safety, and PK of AZD0292 administered IV in participants 12 years of age and older with bronchiectasis and chronic Pseudomonas aeruginosa colonization

Trial Identifier: D7700C00003
Sponsor: AstraZeneca
Start Date: November 2025
Primary Completion Date: December 2027
Study Completion Date: June 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BE Gent, BE, 9000
BE Leuven, BE, 3000
BE Liege, BE, 4000
BE Sint-Niklaas, BE, 9100
DE Frankfurt, DE, 60596
ES Barcelona, ES, 08036
ES Benalmádena, ES, 29631
ES Madrid, ES, 28040
ES Merida, ES, 06800
ES Valencia, ES, 46020
IL Ashkelon, IL, 7830604
IL Haifa, IL, 34362
IL Jerusalem, IL, 91031
IL Ramat Gan, IL, 52621
IL Tel Aviv, IL, 6423906
MY Kuala Lumpur, MY, 59100
MY Puncak Alam, MY, 42300
US, TX Mansfield, TX, US, 76063